| Study Testing Benefits of Ursolic Acid (UA) as a Countermeasure To Myopenia and Insulin Resistance in Chronic Spinal Cord Injury (SCI) (NCT05776862) | University of Miami | 2023-03-27 |
| Extension Study of Efficacy and Safety of LTP001 in Pulmonary Arterial Hypertension Participants (NCT05764265) | Novartis Pharmaceuticals | 2023-03-27 |
| Study of a Novel Type 1 Oral Poliomyelitis Vaccine in Bangladesh (NCT05644184) | PATH | 2023-03-27 |
| Bacteriophage Therapy in Patients With Prosthetic Joint Infections (PJI) (NCT05269134) | Adaptive Phage Therapeutics, Inc. | 2023-03-27 |
| A Study to Evaluate the Efficacy and Safety of CIN-102 (Deudomperidone) in Adults With Diabetic Gastroparesis (NCT05832151) | CinDome Pharma, Inc. | 2023-03-27 |
| MSP3-CRM-Vac4All/ Alhydrogel® Vaccine (NCT05776017) | Vac4All | 2023-03-27 |
| A Study of Botensilimab in Participants With Metastatic Pancreatic Cancer (NCT05630183) | Agenus Inc. | 2023-03-27 |
| Fisetin to Improve Physical Function in Stage I-III Breast Cancer Survivors (NCT05595499) | Jonsson Comprehensive Cancer Center | 2023-03-27 |
| Pembrolizumab and Olaparib Treatment of Extensive Small Cell Lung Cancer (ES-SCLC) (NCT05623319) | Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS | 2023-03-27 |
| Chemotherapy (DA-EPOCH+/-R) and Targeted Therapy (Tafasitamab) for the Treatment of Newly-Diagnosed Philadelphia Chromosome Negative B Acute Lymphoblastic Leukemia (NCT05453500) | University of Washington | 2023-03-27 |
| A Study of mRNA-1011.1, mRNA-1011.2, and mRNA-1012.1 Candidate Seasonal Influenza Vaccines in Healthy Adults (NCT05827068) | ModernaTX, Inc. | 2023-03-27 |
| The Impact of a Virtual Magic Trick Training Program (NCT05664841) | University of Alabama at Birmingham | 2023-03-27 |
| Selinexor, Venetoclax, and Dexamethasone (XVenD) in t(11;14)-Positive Relapsed/Refractory Multiple Myeloma (NCT05530421) | University of Miami | 2023-03-26 |
| Effect of Lidocaine Transdermal Patch as Add-On Therapy in Treatment of Oxaliplatin Induced Peripheral Neuropathy in Colorectal Cancer Patients (NCT05866653) | Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | 2023-03-25 |
| Overcoming Nicotine Dependence to Enable Quitting (NCT05513872) | Rush University Medical Center | 2023-03-24 |
| The Use of a Porcine Collagen Matrix for the Prevention of Buccal Bone Wall Resorption During Implant Placement in the Aesthetic Zone. (NCT06622759) | Aristotle University Of Thessaloniki | 2023-03-24 |
| Monthly Injectable BUP for MA Use Disorder (MURB) Trial (NCT05283304) | Madhukar H. Trivedi, MD | 2023-03-24 |
| Single Arm Study of Neoadjuvant Dostarlimab in Stage II and III Deficient Mismatch Repair Colon Cancers (NCT05239546) | University of Iowa | 2023-03-24 |
| Testing Cabozantinib With or Without Atezolizumab in Patients With Advanced Papillary Kidney Cancer, PAPMET2 Trial (NCT05411081) | National Cancer Institute (NCI) | 2023-03-24 |
| Preoperative mFOLFIRINOX (or Gem-Nab-P) +/- Isotoxic High-dose SBRT for Borderline Resectable Pancreatic Adenocarcinoma (NCT05083247) | Erasme University Hospital | 2023-03-24 |
| Phase 2B Micronized DHACM vs. Saline in the Treatment of Knee Osteoarthritis (NCT05796765) | MiMedx Group, Inc. | 2023-03-24 |
| Everolimus Aging Study (NCT05835999) | University of Wisconsin, Madison | 2023-03-24 |
| A Multiple Antigen Vaccine (STEMVAC) for the Treatment of Patients With Stage IV Non-Small Cell Lung Cancer (NCT05242965) | University of Washington | 2023-03-24 |
| F573 for Injection for the Treatment of Liver Injury/Failure (NCT05689645) | Beijing Continent Pharmaceutical Co, Ltd. | 2023-03-24 |
| Durvalumab Maintenance After Thoracic Chemoradiotherapy in Frail Small Cell Lung Cancer Patients Whose Disease is Limited to the Thorax (NCT05617963) | UNICANCER | 2023-03-24 |
| A Dose Escalation Study of Levetiracetam in the Treatment of Neonatal Seizures (NCT05610085) | University of California, San Diego | 2023-03-24 |
| Secondary BRain Metastases Prevention After Isolated Intracranial Progression on Trastuzumab/Pertuzumab or T-DM1 in Patients With aDvanced Human Epidermal Growth Factor Receptor 2+ brEast Cancer With the Addition of Tucatinib (NCT05323955) | Carey Anders, M.D. | 2023-03-23 |
| A Phase II Study to Evaluate the Efficacy and Safety of Pembrolizumab in Combination With Mitotane in Patients With Advanced Adrenocortical Carcinoma (NCT05634577) | M.D. Anderson Cancer Center | 2023-03-23 |
| A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies (NCT05669430) | GV20 Therapeutics | 2023-03-23 |
| Short Course Radiotherapy for the Treatment of Patients With Glioblastoma, SAGA Study (NCT05781321) | Mayo Clinic | 2023-03-23 |
| A Study to Optimize Subretinal Surgical Delivery and to Evaluate Safety and Activity of Opregen in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration (GAlette); Adaptive Optics (AO) Retinal Imaging Substudy in Association With Study GR44251 (NCT05626114) | Genentech, Inc. | 2023-03-23 |
| A Clinical Study of IMP4297 Capsule (JS109) Combined With Irinotecan in the Treatment of Advanced Malignant Solid Tumors (NCT05824455) | Shanghai Jun Pai Ying Shi Therapeutics Co., Ltd. | 2023-03-23 |
| Cryoablation Combined With Sintilimab Plus Lenvatinib in Patients With Immune Checkpoint Inhibitor Previously Treated Advanced Biliary Tract Cancer （CASTLE-08） (NCT05781074) | Fudan University | 2023-03-23 |
| Tafasitamab and Rituximab for Front-Line Treatment of Post-Transplant Lymphoproliferative Disorder (NCT05786040) | Timothy Voorhees | 2023-03-23 |
| 5-Azacytidine and/or Nivolumab in Resectable HPV-Associated HNSCC (NCT05317000) | Barbara Burtness | 2023-03-23 |
| To Understand the Safety and Effects of a C. Difficile Vaccine With New Adds-Ons That Will Be Given to Healthy Adults (NCT05805826) | Pfizer | 2023-03-23 |
| A Study of TTI-101 as Monotherapy and in Combination in Participants With Locally Advanced or Metastatic, and Unresectable Hepatocellular Carcinoma (NCT05440708) | Tvardi Therapeutics, Incorporated | 2023-03-23 |
| HEALEY ALS Platform Trial - Regimen F ABBV-CLS-7262 (NCT05740813) | Merit E. Cudkowicz, MD | 2023-03-23 |
| Comparison of Al18F-NOTA-LM3 With 68Ga-DOTATATE and 68Ga-NODAGA-LM3 PET/CT in Patients With Well-differentiated Neuroendocrine Tumors (NCT06056362) | Peking Union Medical College Hospital | 2023-03-23 |
| Efficacy and Safety of SPH3127 Tablets on Treating the Diabetic Kidney Disease (NCT05593575) | Shanghai Pharmaceuticals Holding Co., Ltd | 2023-03-22 |
| A Study of NT 201 Doses in the Treatment of Platysma Prominence (NCT05773053) | Merz Aesthetics GmbH | 2023-03-22 |
| Camrelizumab in Combination With Cetuximab and Chemotherapy for Relapsed/Metastatic HNSCC Patients (NCT05673577) | Fudan University | 2023-03-22 |
| A Phase 2 Randomized Multisite Trial to Inform Public Health Strategies Involving the Use of MVA-BN Vaccine for Mpox (NCT05740982) | National Institute of Allergy and Infectious Diseases (NIAID) | 2023-03-22 |
| KD6001 in Combination With Anti-PD-1 Antibody in Patients With Advanced Melanoma (NCT05723432) | Shanghai Kanda Biotechnology Co., Ltd. | 2023-03-22 |
| Safety & Immunogenicity of RVM-V001/RVM-V002 or RVMV001+RVMV002 (Co Administered as Separate Injections) in Healthy Individuals (NCT05788185) | RVAC Medicines (US), Inc. | 2023-03-22 |
| A Study To Evaluate The Efficacy, Safety, Pharmacokinetics, And Pharmacodynamic Effects Of GDC-6599 In Patients With Chronic Cough (NCT05660850) | Genentech, Inc. | 2023-03-22 |
| Hemolysis Related Complications in SCD. A Phase II Study With Voxelotor (NCT05199766) | Assistance Publique - Hôpitaux de Paris | 2023-03-22 |
| Study of Avutometinib (VS-6766) +Defactinib With Gemcitabine and Nab-paclitaxel in Patients With Pancreatic Cancer (NCT05669482) | Verastem, Inc. | 2023-03-22 |
| Using TEE to Evaluate the Effect of Levosimendan on Patients With ARDS Associated With RVD During MV (NCT05768230) | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 2023-03-22 |
| A Randomized Controlled Trial With Rituximab for Psychotic Disorder in Adults (NCT05622201) | Region Örebro County | 2023-03-21 |
| Neoadjuvant KRAS G12C Directed Therapy With Adagrasib (MRTX849) With or Without Nivolumab (NCT05472623) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2023-03-21 |
| A Randomized, Controlled Study of Repeat Dose Sustained Release Lidocaine for Treatment of Chronic Scrotal Pain (NCT05707208) | Sustained Therapeutics Inc. | 2023-03-21 |
| A Clinical Trial of BGT-002 Tablets in Subjects With Nonalcoholic Steatohepatitis (NCT06491576) | Burgeon Therapeutics Co., Ltd. | 2023-03-21 |
| Rescue Thrombolysis for Medium Vessel Occlusion (RESCUE-TNK) (NCT05657470) | General Hospital of Shenyang Military Region | 2023-03-21 |
| A Phase IIa Randomized, Double-Blinded Clinical Trial of Naproxen or Aspirin for Cancer Immune Interception in Lynch Syndrome (NCT05411718) | M.D. Anderson Cancer Center | 2023-03-21 |
| The Immunomodulatory Effect of Sugammadex After Total Hip Replacement Surgery Under Neuraxial Anaesthesia: a Pilot Study (NCT05723406) | Radboud University Medical Center | 2023-03-21 |
| Surgical Conversion of Candonilimab (AK104) Plus Paclitaxel, S-1 and Apatinib for Unresectable Advanced G/GEJ Cancer (NCT05853172) | Tianjin Medical University Cancer Institute and Hospital | 2023-03-21 |
| A Study to Evaluate the Safety and Efficacy of CyPep-1 in Combination With Pembrolizumab for the Treatment of Advanced or Metastatic Cancers (NCT05383170) | Cytovation AS | 2023-03-21 |
| Combined Ketamine and Midazolam for Generalized Convulsive Status Epilepticus (NCT05779657) | Sohag University | 2023-03-21 |
| Role of the Gut Vascular Barrier and Microbiota in Autism Spectrum Disorders (NCT07450443) | Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta | 2023-03-21 |
| Effectiveness of Different Fibrinogen Preparations in Restoring Clot Firmness (NCT05780125) | IRCCS Policlinico S. Donato | 2023-03-20 |
| Evaluation Safety and Explore Efficacy Long-term Follow-up Study on Subjects Receiving SMUP-IA-01 or Active Control (NCT06798727) | Medipost Co Ltd. | 2023-03-20 |
| Efficacy and Safety of Concurrent Chemoradiotherapy With Oral Vinorelbine in Patients With Non-small Cell Lung Cancer (NCT06540950) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2023-03-20 |
| Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment (NCT05432804) | National Cancer Institute (NCI) | 2023-03-20 |
| Chinese Medicine for Patients With Psoriasis (NCT05295979) | Chinese University of Hong Kong | 2023-03-20 |
| Lentiviral Gene Therapy for p47 AR-CGD (NCT05207657) | Great Ormond Street Hospital for Children NHS Foundation Trust | 2023-03-20 |
| Body Massage Oil, Facial Mask, and Ready-to-drink Jelly From Snake Fruit (NCT06227260) | Burapha University | 2023-03-20 |
| The Breast Cancer Survivors and Partners Online Research Together (SUPORT) Project (NCT05676255) | University of Arizona | 2023-03-20 |
| Rituximab in Combination With Glofitamab and Polatuzumab Vedotin in Patients With Previously Untreated Aggressive B-cell Lymphoma Ineligible for R-CHOP (NCT05798156) | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | 2023-03-20 |
| A Phase 2b Clinical Study With a Combination Immunotherapy in Newly Diagnosed Patients With Glioblastoma (NCT04485949) | Imvax | 2023-03-20 |
| High Intensity Step Training After Traumatic Brain Injury (NCT05702138) | Craig Hospital | 2023-03-20 |
| Repurposing Fenofibrate in Modulating mTOR/NLRP3 Inflammasome in Patients With Ulcerative Colitis (NCT05781698) | Tanta University | 2023-03-20 |
| Glutamatergic Modulation as a Treatment for Depressive Symptoms Among Patients With Post-acute Sequelae of COVID (PASC): A Pilot Trial (NCT05690503) | New York State Psychiatric Institute | 2023-03-20 |
| Acetazolamide in Persons With Type 1 Diabetes - Dose Finding (NCT05473364) | University of California, San Diego | 2023-03-20 |
| Umbrella Trial of Subtype-Targeted Therapies in ER+/HER2- Breast Cancer (NCT05101564) | Jennifer Lee Caswell-Jin | 2023-03-20 |
| Comparison of Efficacy Between Combination of Amitriptyline-propranolol and Pizotifen for Migraine Prophylaxis. (NCT06158230) | Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | 2023-03-19 |
| Pharmacodynamic Blood Characteristics of ICP-332 in Patients With Moderate to Severe Atopic Dermatitis (NCT05702268) | Beijing InnoCare Pharma Tech Co., Ltd. | 2023-03-18 |
| A Study to Evaluate VTX2735 in Patients With Cryopyrin-associated Periodic Syndrome (NCT05812781) | Zomagen Biosciences Ltd. | 2023-03-18 |
| Pharmacokinetics, Efficacy and Safety of Olokizumab In Patients With Juvenile Idiopathic Arthritis (NCT07517575) | R-Pharm International, LLC | 2023-03-17 |
| NEOadjuvant Dendritic Cell Vaccination for Ovarian Cancer (NCT05773859) | Radboud University Medical Center | 2023-03-17 |
| Study of Onvansertib in Combination With FOLFIRI and Bevacizumab Versus FOLFIRI and Bevacizumab for Second Line Treatment of Metastatic Colorectal Cancer in Participants With a Kirsten Rat Sarcoma Virus Gene (KRAS) or Neuroblastoma-RAS (NRAS) Mutation (NCT05593328) | Cardiff Oncology | 2023-03-17 |
| Systemic and Central Inflammation in AD (NCT06384378) | The Methodist Hospital Research Institute | 2023-03-17 |
| The Investigation of Vitamin D and Menstrual Cycles Trial, the inVitD Trial: A Phase II Clinical Trial (NCT05050916) | National Institute of Environmental Health Sciences (NIEHS) | 2023-03-17 |
| Sodium-Glucose Cotransporter-2 Inhibitor (SGLT2) in Major Depressive Disorder (MDD) (NCT05757791) | NYU Langone Health | 2023-03-17 |
| Envafolimab Combined With GEMOX in First-line Treatment of Advanced GBC (NCT06013943) | Eastern Hepatobiliary Surgery Hospital | 2023-03-17 |
| Combination Immunotherapy in Colorectal Cancer (NCT05571293) | Weill Medical College of Cornell University | 2023-03-17 |
| Synbiotics and Fecal Microbiota Transplantation to Treat Non-Alcoholic Steatohepatitis (NCT05821010) | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2023-03-17 |
| PirfenidoneVsPlacebo as Prophylaxis Against Acute Radiation-induced Lung Injury Following HFRT in Breast Cancer Patients (NCT05704166) | Fujian Medical University Union Hospital | 2023-03-16 |
| Study of Novel Treatment Combinations in Patients With Lung Cancer (NCT05633667) | Gilead Sciences | 2023-03-16 |
| A Study to Evaluate the Efficacy and Safety of TL118 in Solid Tumors Patients (NCT06010342) | Teligene US | 2023-03-16 |
| Palliative Dose Escalated Radiation for Painful Non-Spine Bone Metastases and Painful Non-Bone Metas (NCT05419518) | Rutgers, The State University of New Jersey | 2023-03-16 |
| Nicotinamide Riboside and Prevention of Cancer Therapy Related Cardiac Dysfunction in Breast Cancer Patients (NCT05732051) | University Hospital, Akershus | 2023-03-16 |
| Modulation of the Gut Microbiome With Pembrolizumab Following Chemotherapy in Resectable Pancreatic Cancer (NCT05462496) | Icahn School of Medicine at Mount Sinai | 2023-03-16 |
| A Study of SHR-A1811 Monotherapy or Combined With Pyrotinib Maleate as Neoadjuvant Treatment in HER2-positive Breast Cancer Patients (NCT05635487) | Shengjing Hospital | 2023-03-16 |
| Study of ABBV-668 Oral Capsules to Assess Adverse Events and Change in Disease Activity in Adult Participants With Moderate to Severe Ulcerative Colitis (NCT05570006) | AbbVie | 2023-03-16 |
| Respiratory Outcomes After Early Vitamin D Supplementation in Infants Born Extremely Preterm (NCT05615311) | University of Alabama at Birmingham | 2023-03-16 |
| Fractionated Busulfan Conditioning Regimen for Allo-HSCT in Non-remission Myeloid Malignancies (NCT05807659) | Sichuan University | 2023-03-16 |
| Frespaciguat (MK-5475) INSIGNIA-PH-COPD: A Study of the Efficacy and Safety of Frespaciguat (an Inhaled sGC Stimulator) in Adults With PH-COPD (NCT05612035) | Merck Sharp & Dohme LLC | 2023-03-16 |
| Study of VGA039 in Healthy Volunteers and Patients With Von Willebrand Disease (VIVID) (NCT05776069) | Vega Therapeutics, Inc | 2023-03-16 |
| Cannabis' Impact on Alcohol Consumption (NCT05389930) | Brown University | 2023-03-16 |